Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanoparticle Intracanal Medicaments for Post-operative Pain in Necrotic Pulp
NCT04338633Unknown
- Sponsor
- Minia University
- Start
- Apr 2020
- Primary completion
- Nov 2020
- Modality
- Nanoparticles, DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised trial of calcium hydroxide nanoparticles and silver nanoparticles in pulp necrosis (3 arms), sponsored by Minia University. Primary endpoint: Change in post operative pain at 96 hours. Status: unknown.
02
Drugs
calcium hydroxide nanoparticlessilver nanoparticles
03
Conditions
pulp necrosis
Beyond the preview
Go deeper on NCT04338633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04338633.